MPL and myeloproliferative disorder: Importantly, while the absence of functional MPL causes CAMT in humans, MPL cell-surface expression is impaired, but not absent in MPN HSC and HPC, which, as demonstrated experimentally (59), should give normal HSC and HCP a survival advantage when exposed to a THPO antagonist.